|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FNCH
|
Finch Therapeutics Group, Inc.
|
US
|
NASDAQ
|
|
HCM
|
Hutchison China MediTech Limited
|
US
|
NASDAQ
|
|
IMMX
|
Immix Biopharma, Inc.
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
LABP
|
Landos Biopharma, Inc.
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RDHL
|
Redhill Biopharma Ltd.
|
US
|
NASDAQ
|
|
STAB
|
Statera Biopharma, Inc.
|
US
|
NASDAQ
|
|
AXIM
|
Axim Biotechnologies
|
US
|
OTC
|
|
BGLC
|
Bionexus Gene Lab Corp
|
US
|
OTC
|
|
CHSYF
|
China Medical Sys Hlds
|
US
|
OTC
|
|
GLPGF
|
Galapagos Genomics Ord
|
US
|
OTC
|
|
IVBXF
|
Innovent Biologics Inc
|
US
|
OTC
|
|
UCBJF
|
UCB SA
|
US
|
OTC
|
|
UCBJY
|
UCB SA
|
US
|
OTC
|
|
TRLS
|
TRLSTrellus Health plc
|
UK
|
LSE
|
|
GLPG
|
Galapagos NV
|
NL
|
AS
|
|
TUB
|
Tubize-Fin
|
BE
|
BR
|